MENU
MGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MeiraGTx Holdings (MGTX) Ownership - Who owns MeiraGTx Holdings?

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
655 Third Avenue
Phone
+1 646 860-7985
Employees
403
Web
https://www.meiragtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.12B
P/E Ratio
N/A
Total Cash
71.54M
Projected Growth
N/A
Total Debt
87.53M
Revenue
79.76M
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
0.77
Total Debt/Equity
N/A
Revenue/Share
0.98 USD as % of share price
View a ticker or compare two or three
MGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel treatments for inherited and acquired genetic disorders

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
655 Third Avenue
Phone
+1 646 860-7985
Employees
403
Web
https://www.meiragtx.com